Osteoporosis is a metabolic bone disease characterized by a reduction in bone mass and microarchitectural deterioration of bone tissue, resulting in skeletal fragility and susceptibility to fractures, especially of the wrist, spine, and hip. 1, 2) The approach to the design of antiosteoporotic drugs follows the two basic processes of bone remodeling including agents that target the prevention of bone resorption (estrogen, calcitonin, bisphosphonates, raloxifene) as well as agents that stimulate bone formation (fluoride, anabolic steroids). [3] [4] [5] [6] [7] [8] [9] Postmenopausal osteoporosis induced by estrogen deficiency is the most common cause of age-related bone loss. Estrogen replacement therapy (ERT) can help relieve postmenopausal syndrome, 10, 11) but has a low acceptance rate due to the possible increase in the risks of breast and endometrial cancers with long-term use. 12) In addition, the most frequently used antiosteoporotic drugs were developed in affluent countries and the costs are too high to benefit a large population in the developing or even developed countries for the prevention and treatment of osteoporosis. Thus an alternative approach for the management of osteoporosis is desirable.
Chinese herbal medicine has been widely used in clinical practice to treat bone disease for thousands of years and will undoubtedly continue to be used as a cost-effective alternative to commercial pharmaceutical products by traditional users. [13] [14] [15] [16] Drynaria fortunei (KUNZE) J. SM. is a folk medicine with a long history of safe use for the treatment of bone fractures and joint diseases in China. Many studies reported on the therapeutic effects of the rhizomes of Gusuibu on osteoporosis and bone fracture, [17] [18] [19] [20] especially of the flavonoids tested in the ovariectomized (OVX) rat model. 21, 22) However, few phytochemical studies have been conducted on the active constituents leading to the osteoprotective effects of the rhizome. 23) In our bioactive screening assay, the 60% alcohol extract of D. fortunei was found to stimulate the proliferation of osteosarcoma UMR106 cells. Activity-guided isolation was carried out, following examination in OVX models as well as UMR106 cells, which were used to test the samples in vivo and in vitro, respectively. The present study deals with the isolation and identification of 11 compounds from the active fraction of the extract of D. fortunei and the effects of these compounds on the proliferation of UMR106 cells. Two were new compounds and eight were reported for the first time from the Drynaria genus. This was the first study of their proliferative activity in osteoblast-like cells, except for naringin. 23) The main components of the active fraction were clarified using HPLC.
Results and Discussion
Effects of 60% line with osteoblast-like phenotypic properties. Insulin-like growth factor (IGF)-I is a peptide growth factor that can stimulate bone formation and was used as a positive control in the present study. The 60% ethanol extract of D. fortunei (DFE) stimulated the proliferation of UMR106 cells by 11.79% (pϽ0.05, Table 1 ) and 12.75% ( pϽ0.05, Table 1 ) at concentrations of 1 mg/ml and 100 ng/ml, respectively. DFE was chromatographed on a D-101 macroporous resin column and eluted with gradients of water, and 30%, 50%, and 95% alcohol to give DFA (water ethanol eluate), DFB (30% and 50% ethanol eluate), and DFC (95% ethanol eluate). Table 1 shows the effects of DFE and fractions DFA, DFB, and DFC, on the proliferation of UMR106 cells. DFB increased proliferation by 10.26% ( pϽ0.05), 16.42% (pϽ0.05), and 20.73% (pϽ0.01) at concentrations of 10 mg/ml, 1 mg/ml, and 0.1 mg/ml, respectively. DFC also stimulated the proliferation of UMR106 cells by 13.8% ( pϽ0.05) and 9.79% (pϽ0.05) at concentrations of 10 mg/ml and 1 mg/ml, respectively. DFA showed no effects on the proliferation of UMR106 cells. As shown in Fig. 1 , DFB significantly increased both the trabecular bone mineral density (BMD) and the total BMD of the mouse femoral head. 29) maltol glucoside (9), 30, 31) 32) and (Ϫ)-epicatechin (11) 33) by comparison of their spectral data (UV, IR, NMR, and MS) with those reported previously. Figure 2 exhibits the HPLC fingerprint of DFB. The main components in it were compounds 1, 2, 3, 6, and 10 and they were thought to be the key principles in osteoprotective activity.
Compound 1 was isolated as pale yellow powder and shown to be a flavonoid based on TLC visualization under UV light, which was confirmed by its UV absorption maxima at 346 nm, 266 nm, and 202 nm in methanol (typical of flavonol glycosides). The IR absorption bands at 3287, 1659, and 1589 cm Ϫ1 showed the presence of hydroxyl, carbonyl, and aromatic rings respectively. HR-ESI-TOF-MS showed a pseudo molecular ion peak at m/z 603. , suggesting that there were one hexose unit and one pentose unit in 1. The monosaccharides obtained after acid hydrolysis of 1 were derivatized into aldononitrile peracetate derivatives and analyzed with GC-MS using authentic samples as references. The absolute configurations of the sugar residues were assumed to be D-glucose and L-arabinose. The The anomeric signal of the glucose unit appeared at d C 100.8 48 Vol. 56, No. 1 
Fig. 2. HPLC Chromatogram of Antiosteoporotic Fraction (DFB) and Its Main Components
The upper line (a) is the HPLC profile of DFB, while the lower one (b) is the mixture of the five labeled compounds. HPLC system, Agilent series 1100; HPLC conditions: column, Shimadzu C 18 ; column 250ϫ4.6 mm; mobile phase, (A) H 2 O, (B) MeOH; elution program, 0-25 min, linear gradient from 10%B to 40%B in 60 min and then 100%B maintained for 10 min; flow rate, 1.00 ml/min; detection wavelength, 254 nm; injection volume: 10 ml; oven temperature, 30°C. C-7) suggested that the glucopyranosyl unit was located at C-3 and that the arabinofuranosyl unit was attached to C-7. Each carbohydrate spin system was assigned by exhaustive analyses of 1 H-1 H COSY, HMQC, and HMBC experiments. On the basis of all spectroscopic data, 1 was determined to be kaempferol-3-O-b-Dglucopyranosyl-7-O-a-L-arabinofuranoside, which is a new flavonol glycoside. Table 2 gives the NMR data for 1. , suggesting the attachment of two sugars, a 6-deoxyhexose and a hexose. The monosaccharides obtained after acid hydrolysis of 2 were derivatized into aldononitrile peracetate derivatives and analyzed by GC-MS using authentic samples as references. The absolute configurations of the sugar residues were assumed to be D-glucose and L-rhamnose.
1 H-and 13 C-NMR spectra (Table 3) resembled those of compound 5, except for the additional of six signals due to a sugar moiety and also were similar to those of compound 3, differing only in the observation of ABM-type aromatic signals instead of A 2 B 2 -type signals, and thus it has the same aglycone as compound 5 and the same O-neohesperidoside as compound 3. The MS 2 spectrum of , and the loss of 136 mass units is characterisitc of a flavanoid 7-O-hesperidose, as shown by a retro-Diels-Alder (RDA) fragmentation in the C-ring of the aglycone involving a cleavage of bonds 1 and 3 (bonds 1 and 3 refer to the O-C-2 and C-3-C-4 bonds of the C-ring). 38) This is also confirmed by the loss of 120 mass units in the MS 2 of naringin (compound 3) in the negative mode in the same RDA fragmentation. In the B-ring, 3,5-substitution were confirmed by the ABM system protons at d H 6.91 (1H, br s) and 6.78 (2H, br s). The CD spectrum showed a positive Cotton effect at 328 nm and a negative one at 283 nm, consistent with the S-configuration at C-2. 25, 39) Based on the information mentioned above, compound 2 was identified as (2S)-5,7,3Ј,5Ј-tetrahydroxy-flavanone 7-O-neohesperidoside, which is a new flavanone glycoside because of the 3Ј,5Ј-substitute mode in the B ring of the aglycone.
Proliferative Effects of Eeleven Flavonoids from Rhizomes of D. fortunei Table 3 
Experimental
General The optical rotations were measured with a P-1020 digital polarimeter (Jasco, Japan). The UV and IR spectra were recorded on UV2401PC (Shimadzu, Japan) and FT/IR-8400 (Shimadzu, Japan) spectrophotometers, respectively. NMR ( 1 H-NMR: 400 MHz, 13 C-NMR: 100 MHz) spectra were measured on an Avance 400 Fourier transform spectrometer (Bruker). Chemical shifts are expressed in d (ppm) and coupling constants (J) are reported in Hertz (Hz). The ESI-MS were obtained on a Bruker Esquire 2000 mass spectrometer. HR-ESI-MS spectra were recorded using a Micromass Q-TOF mass spectrometer. CD data were recorded on a JASCO J-715 instrument. GC-MS were obtained on a Shimadzu GC-MS-2010 gas chromatograph mass spectrometer with AOC-20i autoinjection and AOC20s autosampling. Preparative HPLC and analytical HPLC were performed on a Shimadzu Pak, UV detector for RP-HPLC. Silica gel 60 (Qingdao Haiyang Chemical Co., Ltd., China), Sephadex LH-20 (Advanced Technology Industrial Co., Ltd.), ODS (40-75 mm, Fuji Silysia Chemical Ltd., Japan), and D-101 macroporous resin (Tianjin Chemical Co., Ltd., China) were used as column chromatography stationary phases. D-glucose, L-arabinose, and L-rhamnose were purchased from Sigma Chemical Company (St. Louis, MO, U.S.A.).
The UMR106 cell line was purchased from the American Type Culture Collection, no. CRL-1661. Dulbecco's modified Eagle's medium (DMEM), FBS, phenol red-free DMEM, charcoal-stripped FBS, and 0.5% trypsin-EDTA 5.3 mM (10ϫ) were purchased from Gibco BRL. Penicillin-streptomycin-glutamine (100ϫ) was obtained from Invitrogen Corporation. Ninety-six-well plates and plastic dishes (100ϫ20 mm) for cell culture were obtained from Falcon (U.S.A.). 3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfonyl)-2H-tetrazolium) (MTS) was a product of USBTM (Austria). All compounds were dissolved in DMSO at a concentration of 10 Ϫ2 M as stock solution, diluted with DMSO to gradients of 10
10
Ϫ4 M, 10 Ϫ5 M and then freshly prepared at a dilution of 1 : 1000 in phenol red-free DMEM supplemented with 1% charcoal-stripped FBS.
Seventy 6-month-old female C57BL/6J mice were purchased from Guangzhou University of Traditional Chinese Medicine (Guangzhou, China). Bone mass was measured with peripheral quantitative computerized tomography (pQCT) with an XCT2000 machine (Norland Stratec Medizintechnik GmbH, Birkenfeld, Germany). Regular diet (0.6% Ca) was purchased from Harlan Teklad (Madison, WI, U.S.A.) and the formula was referenced as the normal Ca diet in a previous study. 40) Plant Materials Rhizomes of D. fortunei were collected in Guizhou province, China, in July 2005 and were identified by Professor Rong-Han Zhou (Chinese Pharmaceutical University, Nanjing, Jiangsu, China). A voucher specimen is preserved in the Shenzhen Research Center of Traditional Chinese Medicines and Natural Products, Shenzhen, China.
Extraction and Isolation The rhizomes of D. fortunei (50 kg) were cut and extracted with 60% ethanol (400 l, reflux, 2 h, ϫ2) to yield a 60% ethanol extract (DFE, 3.4 kg). DFE was chromatographed on a D-101 macroporous resin column (f 25ϫ150 cm) and eluted with gradients of water and 30%, 50%, and 95% alcohol to give DFA (water ethanol eluate, 2.2 kg), DFB (30% and 50% ethanol eluate, 0.6 kg), and DFC (95% ethanol eluate, 0.072 kg). The 0.2 kg DFB fraction was subjected to silica gel column chromatography (f 7. . Fr. 5 (72 g) was chromatographed on MPLC on ODS (f 2ϫ20 cm) with MeOH/H 2 O (10-100%) to yield five subfractions. Subfraction 5-1 (8 g) was subjected to Sephadex LH-20 column chromatography (f 3ϫ41 cm) with CHCl 3 /MeOH (30%) to yield nine subfractions. Subfraction 5-1-4 was then subjected to preparative RP-HPLC eluted with MeOH/H 2 O (rϭ0.949) to afford 6 (100 mg), 2 (300 mg), 1 (12 mg), and 3 (100 mg) Fr. 6 (20 g) was chromatographed on MPLC on ODS (f 2ϫ20 cm) with MeOH/H 2 O (10-100%) to yield five subfractions. Subfraction 6-2 (6.4 g) was then subjected to preparative RP-HPLC eluted with MeOH/H 2 O (rϭ0.958) to afford four subfractions. Subfraction 6-2-3 was subjected to Sephadex LH-20 column chromatography (f 1.5ϫ41 cm) with MeOH/H 2 O (70%) to yield 7 (34 mg).
Compound 1 and 2 (each 2 mg) were dissolved in 1 N HCl (2 ml) and then heated to 80°C for 2 h. The solvent was removed under N 2 . After extraction with acetic ether, the aqueous layer was concentrated to dryness using N 2 . The residue was dissolved in 0.1 ml of dry pyridine and then L-cysteine methyl ester hydrochloride in pyridine (0.06 M, 0.1 ml) was added to the solution. The reaction mixture was heated at 60°C for 2 h. After drying with N 2 , 0.1 ml of N-(trimethylsilyl)imidazole was added, followed by heating at 60°C for 1 h. The product was partitioned between cyclohexane and H 2 O (0.1 ml each), and the organic layer was analyzed using gas chromatography (GC). 41, 42) GC-MS analysis conditions were: column DB-50, 25 mmϫ30 m; column oven temperature, 150°C (keep 2 min)→300 (keep 10 min); rate, 15°C/min; injection temperature, 250°C; and carrier gas, He (1.0 ml/min). Peaks of the hydrolyzate of 1 were detected at 14.50 min (L-arabinose) and 16 .45 min (D-glucose); and peaks of the hydrolyzate of 2 were detected at 15.28 min (L-rhamnose) and 16.45 min (D-glucose). Treated in the same way, standard D-glucose (Sigma) gave a peak at t R (min) 16.45, L-rhamnose (Sigma) gave a peak at t R (min) 15.28, and L-arabinose (Sigma) gave a peak at t R (min) 14.50.
Cell Culture UMR106 cells were maintained at 37°C in humid air containing 5% CO 2 in DMEM supplemented with 5% FBS and 100 U/ml of penicillin/100 mg/ml of streptomycin. The cells were subcultured every 4 d using 0.05% trypsin-EDTA 0.53 mM. For the experiments, phenol red-free DMEM was used to rule out the possibility of estrogen binding to the phenol red in the culture medium.
Cell Proliferation Assay The proliferative effects of the samples against the UMR106 cell line was determined in the MTS colorimetric assay. The cells were trypsinized (0.05% trypsin-EDTA 0.53 mM) and seeded into 96-well tissue culture plates at a concentration of 7.5ϫ10 3 cells/well. The cells were allowed to attach for 48 h. The medium was removed and replaced with the experimental medium (1% CDT-FBS in phenol red-free DMEM) containing various concentrations of each sample. After 48 h of incubation, 60 ml of MTS (5 mg/ml) was added to each well. The cells were incubated at 37°C in darkness for 1 h, and then the optical density was measured on POLAR star Galaxy at 490 nm. The negative control was 0.1% DMSO. Optical density of the samples at different concentrations without cells was also determined at 409 nm to correct the effect of the sample color. Thus, A sample ϭA sample with cells ϪA sample without cells . The proliferation ratio was expressed as the percentage of the difference of the optical density at 490 nm of the cells treated with test samples minus that of control relative to that of control, i.e., proliferation ratioϭ(A sample ϪA control )/A control .
Statistical Analysis All data are expressed as meanϮS.D. of at least three independent experiments, each performed in tetraplicate. One-way ANOVA with post-hoc multiple comparisons was performed for statistical analysis. A p value of less than 0.05 was regarded as significant.
Animal Study Design After 1 week of acclimatization, 60 mice were ovariectomized (OVX, nϭ60) and 10 other mice were sham-operated (sham). After 10 d of recovery, OVX mice were randomly and equally divided into six groups: OVXϩvehicle; OVXϩ17b estradiol (2 mg/kg); OVXϩDF (880 mg/kg); OVXϩDFA (567 mg/kg); OVXϩDFB (155 mg/kg); and OVXϩDFC (18 mg/kg). The oral administration to all rats continued for 6 weeks. All rats were fed the regular diet in the experimental period. After killing, femurs were collected and stored at Ϫ20°C. When measuring BMD, femurs were scanned and the trabecular BMD and total BMD in femoral heads were measured using pQCT. 24) 
